University of Milan at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University of Milan takes part in 5 sessions at ESMO 2026 in Madrid. Its program mixes clinical topics, such as myelofibrosis risk assessment, invasive lobular breast cancer and immune checkpoint inhibitors in lung cancer, with access to cancer care worldwide. It addresses medicine shortages and the European response, and whether adapting treatment standards is justified when resources are limited.
| Organization | ESMO 2026 Attendance |
|---|---|
University of Milan Milan, Italy | |
Public research university in Milan, Italy, with a faculty of medicine and surgery. | Talk Fri Oct 23 14:20–14:35 Pharmacology perspective Breast cancer Chair Sat Oct 24 16:30–18:00 Updates on myeloid neoplasms with a focus on medical oncology practice Haematological malignancies Talk Sat Oct 24 17:30–17:50 Prognostic assessment to guide treatment of myelofibrosis Haematological malignancies Chair Sun Oct 25 14:45–16:15 Talk Sun Oct 25 15:30–15:45 Chair Mon Oct 26 10:15–11:45 Talk Mon Oct 26 11:22–11:37 Satellite Mon Oct 26 18:45–19:00 Mechanism of action and differentiating characteristics of immune checkpoint inhibitors Lung & thoracic cancers |
Instantly find 20 buyers from University of Milan
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction